Related Experiment Videos
[Gastroenterologic aspects of connective tissue diseases]
Minerva Medica
|July 14, 1985
Summary
Connective tissue disorders involve widespread inflammation and immune system alterations. This review evaluates gastrointestinal and hepatic manifestations in these acquired diseases, noting their regular occurrence and potential complications.
Area of Science:
- Rheumatology
- Immunology
- Gastroenterology
Context:
- Connective tissue disorders (CTDs) are a diverse group of acquired diseases characterized by systemic immunologic and inflammatory alterations.
- Commonly included CTDs are rheumatoid arthritis, systemic lupus erythematosus, scleroderma, and Sjögren's syndrome, among others.
- These conditions share features like synovitis, vasculitis, and nephritis, impacting multiple organ systems.
Purpose:
- To provide an accurate evaluation of gastrointestinal and hepatic alterations in connective tissue diseases.
- To review the literature concerning the prevalence and clinical significance of GI and hepatic involvement in CTDs.
- To highlight potential complications arising from GI and hepatic manifestations in CTDs.
Summary:
- Gastrointestinal and hepatic involvement, while not primary features, are regularly observed in connective tissue disorders.
- Symptoms such as anorexia, nausea, vomiting, abdominal pain, and malabsorption are common.
- Mesenteric vasculitis can lead to severe complications like intestinal ischemia, infarction, and perforation.
Impact:
- Enhances understanding of the full spectrum of connective tissue disease manifestations.
- Informs clinical practice regarding the recognition and management of GI and hepatic complications in CTDs.
- Provides a foundation for future research into the pathogenesis and treatment of these specific manifestations.